Simultaneous Liver Kidney Transplantation in a Primary Type 2 Hyperoxaluria With Corrected TOF and Severe Cardiomyopathy: A Case Report

IF 3.3 Q2 GASTROENTEROLOGY & HEPATOLOGY

Journal of Clinical and Experimental Hepatology Pub Date : 2024-04-16 DOI:10.1016/j.jceh.2024.101425

Navaneethan Subramanian , Abhishek Yadav , Jithin S. Kumar , George P. Abraham

{"title":"Simultaneous Liver Kidney Transplantation in a Primary Type 2 Hyperoxaluria With Corrected TOF and Severe Cardiomyopathy: A Case Report","authors":"Navaneethan Subramanian , Abhishek Yadav , Jithin S. Kumar , George P. Abraham","doi":"10.1016/j.jceh.2024.101425","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Primary type 2 hyperoxaluria is a very rare genetic disorder,<sup>1,2</sup> where in the progression to renal failure was assumed to be insidious and not very common.<sup>3</sup> PH2 is due to deficient glyoxylate reductase/hydroxypyruvate reductase (GRHPR),<sup>1,2</sup> which was thought to have extra-hepatic production also.<sup>4</sup> The progression to renal failure in these patient subgroups is well documented in the Literature and the role of SLK (simultaneous liver and kidney transplantation) has not been clearly established.<sup>8</sup></p></div><div><h3>Method</h3><p>We present a case report of a young girl with PH2, who successfully underwent SLK, with evidence of reduction in the urine oxalate levels post SLK.</p></div><div><h3>Results</h3><p>PH2, though a rare genetic disease, has a proven potential to progress to chronic renal failure requiring transplantation, renal transplantation alone has not shown any benefit, these patients can be offered SLK as a primary treatment option, to improve the outcomes, this needs further validation with consensus and studies.</p></div>","PeriodicalId":15479,"journal":{"name":"Journal of Clinical and Experimental Hepatology","volume":null,"pages":null},"PeriodicalIF":3.3000,"publicationDate":"2024-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical and Experimental Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0973688324000823","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Primary type 2 hyperoxaluria is a very rare genetic disorder,^1,2 where in the progression to renal failure was assumed to be insidious and not very common.³ PH2 is due to deficient glyoxylate reductase/hydroxypyruvate reductase (GRHPR),^1,2 which was thought to have extra-hepatic production also.⁴ The progression to renal failure in these patient subgroups is well documented in the Literature and the role of SLK (simultaneous liver and kidney transplantation) has not been clearly established.⁸

Method

We present a case report of a young girl with PH2, who successfully underwent SLK, with evidence of reduction in the urine oxalate levels post SLK.

Results

PH2, though a rare genetic disease, has a proven potential to progress to chronic renal failure requiring transplantation, renal transplantation alone has not shown any benefit, these patients can be offered SLK as a primary treatment option, to improve the outcomes, this needs further validation with consensus and studies.

查看原文本刊更多论文

同时进行肝肾移植治疗原发性2型高草酸尿症伴矫正性TOF和严重心肌病：病例报告。

背景原发性2型高草酸尿症是一种非常罕见的遗传性疾病，1,2 其中肾功能衰竭的进展被认为是隐匿的，并不常见。这些亚组患者发展为肾衰竭的情况在文献中已有详细记载，而 SLK（同时进行肝脏和肾脏移植）的作用尚未明确确定。结果PH2 虽然是一种罕见的遗传性疾病，但已被证实有可能发展为慢性肾功能衰竭，需要进行移植手术，而单独进行肾移植手术并未显示出任何益处，这些患者可选择 SLK 作为主要治疗方案，以改善预后，但这需要进一步的共识和研究来验证。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Clinical and Experimental Hepatology GASTROENTEROLOGY & HEPATOLOGY-

CiteScore

4.90

自引率

16.70%

发文量

537

审稿时长

64 days